1) Is adding 72 billion in debt. 2) Declining fs sales. 3) Lost tricare. 4) Government going after PBMs to cut out the middle man. 5) declining rx sales and margins- Walmart now Amazon. 6) highest prices on front store products. 7) No service payroll. 8 higher operating expenses ( pay raises and remodels). 9 Too much middle managers not putting a single dime on the bottom line. Does all this seem like something investors really want to get behind-- I am sure others can add to the list --- feel free too add
5 replies (most recent on top)
Amazon can't be any worse than what I go through with my insurance and paperwork with CVS and CVS Speciality. Get it together people!
As I’m sure the folks at Toys R Us just realized, corporate arrogance and greed will sink a company faster then to can imagine. I’m sure they all wondered “how could this have happened?”, but you can always point back to one or two crucial decisions that led to a their demise. When CVS finally falls we can look back to the day Larry Merlo’s and the Macy’s took over, the debt load of the Aetna deal, and the immense costs to remodel stores neglected for years. That coupled with high prices and understaffed stores chasing customers away, poor in-stock, and a refusal to invest in wages (until now), training and development of our store teams. It’s the blueprint for retail failure.
Everyone beware of Amazon's purchase of PillPack, on 06/28/18, for $1 billion.
In my opinion, this is the beginning of a healthcare transformation in the United States, and I believe, for the good.
Let's see.......................stopped contract on our Reader Boards, i.e., Datronicks now dark, no outside grounds maintenance, outside of mowing, patients perception is lousy....everything is diverse, no matter the consequences from the patients, never a thank you from the "newly" appointed District "Leaders", who know about as much as the dog catcher, and I am not against dog catchers, as anyone, need I say more?
Lawsuits and fees due to payment issues in several states does not bode well for the Aetna deal